Johnson & Johnson Surgical Vision, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$14Mgeneral payments (2019-2025)
$878Kresearch payments (2019-2025)
12,957clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $4.4M
2020 $1.7M
2021 $1.8M
2022 $1.8M
2023 $1.4M
2024 $1.5M
2025 $1.1M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Ophthalmology $10M
Optometrist $1.6M
Cornea and External Diseases Specialist $713K
Ophthalmic Plastic and Reconstructive Surgery $293K
Hematology (Internal Medicine) $142K
Glaucoma Specialist $52K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Daniel Chang Bakersfield, CA Ophthalmology $593,482.23
Marc Odrich Charlottesville, VA Ophthalmology $496,868.45
Joshua Young New York, NY Ophthalmology $466,497.91
Donald Korb Boston, MA Optometrist $372,506.48
Mark Blecher Philadelphia, PA Ophthalmology $347,672.46
Sumit Garg Irvine, CA Cornea and External Diseases Specialist $332,659.61
Christopher Blanton Colton, CA Ophthalmology $331,837.68
Karolinne Rocha Charleston, SC Ophthalmology $299,159.58
Eric Donnenfeld Garden City, NY Ophthalmology $295,175.57
George Waring Mt Pleasant, SC Ophthalmology $283,707.44

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.